Clinical Trial: Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
Study Status: Completed
Recruit Status: RECRUITING
Condition: Postbariatric Hypoglycemia
Study Type: INTERVENTIONAL
Official Title: Phase 2 Crossover, Randomized, Placebo-Controlled, Single-Blind, Repeat Dose Study in Post-Bariatric Hypoglycemia Subjects to Determine the Effect of Mizagliflozin on Adverse Events and Postprandial G
Brief Summary:
This is a phase 2 crossover, randomized, placebo-controlled, single-blind, repeat dose study in PBH subjects to determine the effect of mizagliflozin on adverse events and postprandial glucose excursions.
Read more